Table 4.
Minimally invasive total pancreatectomy.
| First author | n | Type of operation | Indications (n) | Time, minutes (range) | Conversion | Hospital stay, days (range) | Mortality (%) | Morbidity (Clavien-Dindo ≥3) |
|---|---|---|---|---|---|---|---|---|
| Boggi et al.34 2015 |
11 | Laparoscopic robot-assisted | (Malignant) IPMN, PDAC, CP | 600 (400–800) |
0 | 27 (12–88) | 0* | 2 of 11 (18%) |
| Choi et al.81 2012 |
3 | Laparoscopic-assisted | IPMN | 423 | 1 | 20 | 0 | 0 |
| Dallemagne et al.82 2013 |
2 | Laparoscopic | IPMN, pNET | 390 | 0 | 8 | 0 | 0* |
| Giulianotti et al.83 2011 |
5 | Robotic TP | IPMN, PDAC, CP, pNET | 456 | - | 7.2 (5–11) | 0 | 2 of 5 (40%) |
| Kim et al.84 2011 |
1 | Laparoscopic-assisted | Malignant IPMN | 300 | - | 20 | 0 | 0 of 1 (0) |
| Wang et al.85 2017 |
3 | Laparoscopic/robotic | IPMN, pNET | 490 (450–540) |
0 | 18 (8–24) | 0 | 0 of 3 (0) |
| Zureikat et al.86 2015 |
10 | Robotic | IPMN, PDAC, CP | 528 | 1 | 10 ± 3 | 0* | 0 of 10 (0) |
| Total | 35 | 0 | 4 of 32 (13%) |
*90 day mortality/morbidity.
IPMN: intraductal papillary mucinous neoplasm; PDAC: pancreatic ductal adenocarcinoma; CP: chronic pancreatitis; pNET: pancreatic neuroendocrine tumor.